-
Programs and Projects supported by the Slovenian Research Agency
The majority of researches carried out at the Institute are supported financially by the Slovenian Research Agency (ARRS). Comprehensive studies are carried out within research programs and targeted studies within research projects.
Research Programs
Code Program Title Principal Investigator P3-0003 Development and Evaluation of New Approaches to Cancer Treatment Gregor Serša P3-0307 Prognostic and Predictive Factors for Response to Treatment of Breast Cancer and Other Solid Tumors Primož Strojan P3-0321 Characteristics of Malignant Neoplasms Important for Diagnosis, Prognosis and Treatment Outcome Barbara Jezeršek Novaković P3-0352 Moderate and high cancer risk population: counseling, mutational screening and prevention strategies Janez Žgajnar P3-289 Cancer of the Head and Neck - Analysis of Biological Characteristics and An Attempt to Improve Treatment Results Matej Bračko Research Projects
Code Project Title Principal Investigator at the Institute of Oncology L3-9346 Analysis of late effects after treatment of cancer in children and yound adults Berta Jereb J3-0465 Editing of immunosurviellance with the whole cell tumor vaccines and CpG ODN Srdjan Novaković J3-0480 Genetics of hereditary melanoma Marko Hočevar J3-0485 Antiangiogenic siRNA for the treatment of advanced malignant melanoma Maja Čemažar J3-0570 Genetic and radioisotopic methods in diagnostics and therapy of thyroid carcinoma Nikola Bešić L3-0449 New approaches in the treatment of lung cancer II.I Matjaž Zwitter L3-0494 Method for multimodal comparative analysis of 3D volumes, based on CT/MR images Robert Hudej J3- 0020 Three-dimensional soft tissue analysis in slovenian children in the period of growth and development Maja Marolt Mušič L3- 0431 Genetics of breast cancer and hormone replacement therapy Srdjan Novaković L3- 0113 Development and validation of clinical tools developed on International Classification of Functioning, Health and Disability (ICF) Nikola Bešić J1- 0200 Synthesis of novel ruthenium compounds and their potential use in electrochemotherapy of tumors Gregor Serša J3- 0124 The role of recombinat human erythropoietin on gene expresion and signal transduction in breast cancer Simona Borštnar J3- 2359 Role of genetic and therapeutic diversity in individualizing the drug therapy of lung cancer Matjaž Zwitter J3- 2277 Combination of electrogene immune therapy with interleukin-12 and irradition for treatment of experimental tumors Maja Čemažar L3- 2371 Estimation of survival in patients with advanced ovarian cancer based on primary laparoscopical assessment of optimal cytoreduction Aleš Vakselj J3- 2069 Evaluation of magnetic nanoparticles tehnology for transfection of normal and malignant cells Gregor Serša Infrastructure Programs
Šifra Naziv programa Nosilec IP-0302 Lifelong Follow-Up of Survivors of Childhood and Adolescent Cancer and Related Translational Trials Lorna Zadravec Zaletel
- © 2010 - Institute of Oncology Ljubljana
- Legal Notifications / RSS
- Authors